|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
|
|---|---|---|---|
| Assets | |||
| Debt securities available-for-sale excluding accrued interest | |||
| Fixed maturity securities | |||
| Short-term investments | |||
| Other investments, at fair value | |||
| Total investments | |||
| Cash and cash equivalents | |||
| Restricted cash and cash equivalents | |||
| Accrued investment income | |||
| Premiums and other receivables (net of allowance for credit losses of $15.8, 2024: $11.8) | |||
| Amounts due from The Fidelis Partnership (net of allowance for credit losses of $nil, 2024: $nil) | |||
| Deferred reinsurance premiums | |||
| Reinsurance balances recoverable on paid losses (net of allowance for credit losses of $0.3, 2024: $0.2) | |||
| Reinsurance balances recoverable on reserves for losses and loss adjustment expenses (net of allowance for credit losses of $0.9, 2024: $0.8) | |||
| Deferred policy acquisition costs (includes The Fidelis Partnership deferred commissions of $243.4, 2024: $200.2) | |||
| Other assets | |||
| Total assets | |||
| Liabilities and shareholders' equity | |||
| Liabilities | |||
| Reserves for losses and loss adjustment expenses | |||
| Unearned premiums | |||
| Reinsurance balances payable | |||
| Amounts due to The Fidelis Partnership | |||
| Long term debt | |||
| Preference securities | |||
| Other liabilities | |||
| Total liabilities | |||
| Shareholders' equity | |||
| Common shares ($0.01 par, issued and outstanding: 96,651,534, 2024: 111,730,209) | |||
| Common shares held in treasury, at cost (shares held: nil, 2024: 6,570,003) | |||
| Additional paid-in capital | |||
| Accumulated other comprehensive income | |||
| Retained earnings | |||
| Total shareholders' equity | |||
| Non-controlling interests | |||
| Total liabilities and shareholders' equity |
Loading...
